K Pharma

K Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of K Pharma (4896.T) as of Oct 20, 2026 is -916.06 M JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -836.35 M JPY — a change of 9.53% (lower).

EBITDA

-916.06 MJPY

YoY

9.53%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of K Pharma is 2025 -916.06 M JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of K Pharma was 2024 -836.35 M JPY. It decreases by 9.53% lower compared to the previous year.

The K Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2021
-219.03 M JPY
Jan 1, 2022
-353.77 M JPY
Jan 1, 2023
366.06 M JPY
Jan 1, 2024
-836.35 M JPY
Jan 1, 2025
-916.06 M JPY
The K Pharma EBITDA history
YEAREBITDAYoY
-916.06 MJPY+9.53%
-836.35 MJPY-328.47%
366.06 MJPY-203.47%
-353.77 MJPY+61.52%
-219.03 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

K Pharma Stock analysis

What does K Pharma do? K Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about K Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of K Pharma is -916.06 M JPY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of K Pharma changed from -836.35 M JPY to -916.06 M JPY, representing a 9.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) K Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s K Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — K Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — K Pharma